Published online Sep 30, 2007.
https://doi.org/10.4048/jbc.2007.10.3.223
The Experiences of Performing Sentinel Lymph Node Biopsies with the Use of Methylene Blue Dye in Patients with Invasive Breast Carcinoma
Abstract
Purpose
Isosulfan blue has been traditionally used as a tracer to map the lymphatic system during identification of the sentinel lymph node (SLN). However, this vital dye is difficult to obtain in Korea. Radioisotopes such as technetium-labeled sulfur colloid or albumin colloid are also expensive and complex to use. The purpose of this study is to evaluate usefulness of a sentinel lymph node biopsy (SLNB) using methylene blue dye in breast cancer patients.
Methods
We evaluated the sentinel node mapping experience using methylene blue dye from July 2003 to January 2007. Fifty-eight patients with clinical T1-T2 breast cancer without palpable axillary lymph nodes were enrolled. All SLNs were submitted for intraoperative frozen section and hematoxyline and eosin (H & E) stain analysis. For the negative SLNs, serial sections of each SLN specimen were examined by permanent H & E staining and by immunohistochemical techniques (IHC) using cytokeratin. Regardless of the results of a frozen section for the SLNs, a backup level II or III axillary lymph node dissections (ALND) was performed.
Results
Of the 58 patients that underwent a SLNB using methylene blue dye, an SLN was identified in 56 patients (96.6%), and metastatic SLNs were detected in 14 cases. Axillary lymph node metastasis found in 18 out of 58 patients. Thus, the false negative rate for a SLNB was 22.2% (4/18). Two patients had a micrometastasis (pN1mi) and two patients had clusters of isolated tumor cells (pN0[i+]) that were identified in the SLNs by IHC with the additional use of cytoketatin. The sensitivity, specificity, and accuracy of the SLNBs were 77.8%, 100%, and 92.9%, respectively. The false negative rate improved with the accumulation of experience for performing a SLNB (12.5% vs 30.0%). The sensitivity, specificity, positive predictive value, and accuracy of preoperative ultrasonography (USG) for an axillary lymph node metastsis were 50.0%, 95.5%, 81.8% and 81.0% respectively.
Conclusion
Based on our initial experience, methylene blue dye is safe, inexpensive, and a readily available tracer for the SLN mapping, and it could be an effective alternative to the use of isosulfan blue dye for accurately identifying SLNs in early breast caner patients. We expected that the findings of preoperative USG could serve as useful adjuncts to a SLNB.
Fig 1
Stained lymphatics and lymph node during sentinel lymph node biopsy.
Fig 2
Ultrasonographic findings of metastatic axillary lymph node. This lymph node was not palpable. But, this round lymph node had increased vascular flow at perinodal area and cortex on doppler examination and did not display hilar structures.
Fig 3
Cytokeratin immunohistochemical staining of sentinel lymph nodes. (A) isolated tumor cells (pN0[i+]) (×400) and (B)1.5 mm sized micrometastasis (pN1mi) (×100).
Table 1
Clinicopathologic characteristics of patients of the study (N=58)
Table 2
Numbers of identified sentinel and axillary lymph nodes
Table 3
Sentinel and axillary lymph node status on permanent sections (N=56)
Table 4
Metastatic lymph nodes found in sentinel and nonsentinel lymph nodes
Table 5
Outcomes of sentinel lymph node biopsy in learning periods and after learning periods
Table 6
Correlation* between USG findings of axillary lymph node and pathologic results
References
-
Cunningham DK, Mancino AT, Edwards MJ. Axillary staging. In: Singletary SE, Robb GL, Hortobagyi GN, editors. Advanced Therapy of Breast Disease. 2nd ed. Hamilton: BC Decker Inc; 2004. pp. 349-360.
-
-
The Korean Breast Cancer Society. Nationwide korean breast cancer data of 2004 using breast cancer registration program. J Breast Cancer 2006;9:151–161.
-
-
Eldrageely K, Vargas MP, Khalkhali I, Venegas R, Burla M, Gonzalez KD, et al. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue racer compared to isosulfan blue. Am Surg 2004;70:872–875.
-
-
Tuttle TM. Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg 2004;70:407–413.
-
-
Lee CS, Bong JG, Park JH, Lee YS, Paik SM, Shin MJ, et al. The accuracy of the physical examination, mammography, and ultrasonography in the assessment of tumor size and axillary lymph node metastasis in breast cancer patient. J Korean Breast Cancer Soc 2003;6:87–94.
-
-
Tsopelas C, Sutton R. Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 2002;43:1377–1382.
-
-
Giulliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401.
-
-
O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph biopsy in breast cancer: initial experience of Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423–427.
-
-
Hill AD, Mann GB, Borgen PI, Cody HS. Sentinel lymph node mapping in breast cancer. J Am Cancer Soc 1999;188:545–549.
-
-
BIT Druginfo. [accessed Jul 5, 2007].http://www.druginfo.co.kr.
-
-
Lee CS, Bong JG, Park JH, Lee YS, Paik SM, Jeong MH, et al. The accuracy of the physical examination, mammography, and ultrasonography in the assessment of tumor size and axillary lymph node metastasis in breast cancer patient. J Korean Breast Cancer Soc 2003;6:87–94.
-
-
Hwang SE, Moon WK, Cho N, Han WS, Kim SW, Shin HJ, et al. Preoperative evaluation of lymph node metastasis with using ultrasonography for examining the axilla in early stage breast cancer. J Breast Cancer 2006;9:115–120.
-